Filing Analysis
Varex Imaging Corporation has entered into a definitive agreement to be acquired by Teledyne Technologies Incorporated for $18.90 per share in cash. The transaction is expected to close in early 2027, subject to stockholder and regulatory approvals.
🚩 Red Flags
- The company will be delisted from the Nasdaq Global Select Market upon completion of the merger.
📋 Key Facts
- Acquisition price: $18.90 per share in cash.
- Acquirer: Teledyne Technologies Incorporated (via its subsidiary Detect Merger Sub, Inc.).
- Expected closing date: Early 2027.
- Stock treatment: All outstanding shares will be converted to the right to receive $18.90 in cash at the Effective Time.
- Equity compensation: Options, RSUs, and PSUs will accelerate or convert into cash payments based on specific terms defined in the agreement.
- Approval required: Majority vote of Company stockholders at a Special Meeting.
Varex Imaging Corporation issued an 8-K to announce the release of its preliminary financial results for the third quarter and nine months ended July 3, 2026. The filing serves as a formal notice that earnings data will be furnished via press release.
📋 Key Facts
- Preliminary results announced for the three and nine months ended July 3, 2026.
- The announcement was made on August 10, 2026.
- Financial results are contained in Exhibit 99.1 (Press Release).
Varex Imaging Corporation issued an 8-K to announce the release of its preliminary financial results for the fourth quarter and fiscal year ended October 3, 2025.
📋 Key Facts
- The filing announces preliminary results of operations for the twelve months ended October 3, 2025.
- The announcement includes results for the fourth quarter and the full fiscal year 2025.
- A press release was issued on November 18, 2025, as Exhibit 99.1.
Varex Imaging Corporation announced that Kimberley Honeysett will transition out of her role as Senior Vice President, Chief Legal Officer (CLO), and Corporate Secretary. The departure includes a structured transition period through October 2025 and an advisory role lasting until December 2027.
🚩 Red Flags
- Extended advisory period (over 2 years) can sometimes indicate complex legal/compliance handovers or settlement-related structures, though not explicitly stated here.
📋 Key Facts
- Kimberley Honeysett to depart CLO role effective September 5, 2025.
- Transition Period: Will remain as CLO until October 3, 2025, with current salary and benefits.
- Continued Service Period: Will serve as a non-executive employee or advisor from October 4, 2025, through December 12, 2027.
- Compensation during Continued Service: $100,000 annually plus health insurance and other specified benefits.
- Equity: Outstanding equity awards will continue to vest through the end of the Continued Service Period; no new grants will be issued.
- The agreement includes a general release by Ms. Honeysett and indemnification by the Company.
Varex Imaging Corporation issued an 8-K to announce the release of its preliminary financial results for the third quarter and nine months ended July 4, 2025. The filing serves as a formal notice that earnings data will be made public via a press release.
📋 Key Facts
- Company announced preliminary results of operations for the three and nine months ended July 4, 2025.
- The announcement was made on August 7, 2025.
- Detailed financial information is contained in Exhibit 99.1 (Press Release).
Varex Imaging Corporation issued an 8-K to announce the release of its preliminary financial results for the second quarter and first half of fiscal year 2025. The filing serves as a formal notice that preliminary operating results were made public on May 8, 2025.
📋 Key Facts
- Company issued a press release regarding preliminary results for the three and six months ended April 4, 2025.
- The announcement is titled 'Varex Announces Financial Results for Second Quarter Fiscal Year 2025'.
- Filing date: May 8, 2025.
Varex Imaging Corp disclosed that the China Ministry of Commerce (MOFCOM) has announced an anti-dumping investigation into certain medical CT X-ray tubes from the US and India. The company notes it produces these products in the US for shipment to China but has not received formal notice.
🚩 Red Flags
- Potential trade barrier/regulatory risk affecting a key export market (China).
- Anti-dumping investigations can lead to significant tariffs or import restrictions on specific product lines.
📋 Key Facts
- China's MOFCOM announced an anti-dumping investigation into imports of certain medical CT X-ray tubes originating from the United States and India.
- Varex produces medical CT X-ray tubes and inserts in the US and ships them to China.
- The company does not produce these specific items in India.
- As of April 4, 2025, the company has not received formal notice regarding this investigation.
Varex Imaging Corporation held its 2025 Annual Meeting of Stockholders on February 13, 2025. The meeting resulted in the election of seven directors and the approval of several shareholder proposals, including an amendment to include officer exculpation provisions.
🚩 Red Flags
- Proposal Five (Officer Exculpation) received significant opposition, with 6,476,960 shares voting 'Against' compared to 28,757,660 'For'.
📋 Key Facts
- Annual Meeting held on February 13, 2025, with a quorum representing ~92% of shares outstanding (37,910,094 shares).
- Stockholders approved an amendment to the Certificate of Incorporation to limit/eliminate monetary liability for officers regarding breaches of the duty of care.
- Seven directors were elected: Kathleen L. Bardwell, Jocelyn D. Chertoff, Timothy E. Guertin, Jay K. Kunkel, Walter M Rosebrough, Jr., Sunny S. Sanyal, and Christine A. Tsingos.
- Shareholders approved the 2017 Employee Stock Purchase Plan as amended.
- Deloitte & Touche LLP was ratified as the independent registered public accounting firm for fiscal year 2025.
- The company will adopt an annual frequency for 'Say-on-Pay' advisory votes following shareholder preference.
Varex Imaging Corporation issued an 8-K to announce the release of its preliminary financial results for the first quarter of fiscal year 2025, which ended on January 3, 2025.
📋 Key Facts
- The filing is a notice regarding the announcement of preliminary quarterly results.
- Reporting period: Three months ended January 3, 2025.
- The company issued a press release (Exhibit 99.1) containing the financial details.
Varex Imaging Corporation filed an amendment to its 8-K to confirm the termination of a $20.0 million Equipment Credit Agreement with Zions Bancorporation, N.A.
📋 Key Facts
- The Equipment Credit Agreement was dated April 26, 2024, and provided for a secured equipment credit facility of up to $20.0 million.
- The agreement was terminated effective December 20, 2024.
- Termination occurred because the facility was no longer needed following the consummation of an offering of additional senior secured notes on December 20, 2024.
- There were no outstanding amounts under the credit agreement and no early termination penalties incurred.
Varex Imaging Corporation completed a $125 million private offering of 7.875% Senior Secured Notes due 2027 to fund the repayment or repurchase of existing Convertible Notes maturing on June 1, 2025.
🚩 Red Flags
- Refinancing activity: The company is issuing new debt specifically to manage the upcoming maturity of $200 million in Convertible Notes, indicating a need for liquidity management ahead of June 2025.
📋 Key Facts
- Completed a private offering of $125 million in 7.875% Senior Secured Notes due 2027.
- Net proceeds estimated at $124 million to be used for repayment/repurchase of $200 million Convertible Notes maturing June 1, 2025.
- The new notes are part of the same issue as existing 7.875% senior secured notes (of which $243 million is currently outstanding).
- The company intends to terminate an unused $20.0 million Equipment Credit Agreement following this offering.
Varex Imaging Corporation announced the pricing of a $125 million private offering of 7.875% senior secured notes due 2027. This follows an amendment to their existing Revolving Credit and Guaranty Agreement to permit the issuance of these additional notes.
🚩 Red Flags
- Increased leverage: The company is adding $125 million in new senior secured debt to its existing $243 million in similar notes.
- High interest rate: The 7.875% coupon reflects current market conditions for the company's credit profile.
📋 Key Facts
- Offering amount: $125 million in aggregate principal amount.
- Instrument type: 7.875% senior secured notes due 2027.
- The offering is exempt from registration under the Securities Act of 1933.
- Amendment No. 2 to the Revolving Credit and Guaranty Agreement was entered into on December 13, 2024.
- Existing debt includes $243 million of outstanding 7.875% senior secured notes due 2027.
Varex Imaging Corporation issued an 8-K to announce the release of its preliminary financial results for the fourth quarter and fiscal year ended September 27, 2024.
📋 Key Facts
- The filing announces preliminary results of operations for the three months and twelve months ended September 27, 2024.
- The announcement was made via a press release dated November 19, 2024.
- Results pertain to the fourth quarter and full fiscal year 2024.
Varex Imaging Corporation has amended its senior secured revolving credit agreement with Zions Bancorporation to provide greater financial flexibility regarding convertible note payments and debt ratio calculations. The amendments primarily adjust definitions for payment conditions, coverage ratios, and net indebtedness calculations.
🚩 Red Flags
- The amendment specifically addresses flexibility for 'restricted payments' related to convertible notes, which can sometimes indicate a need to manage liquidity or satisfy debt obligations under tight covenants.
📋 Key Facts
- Amended the March 26, 2024 Credit Agreement with Zions Bancorporation, N.A.
- Modified 'Payment Conditions' to allow restricted payments on convertible notes up to the greater of 50% of Consolidated Net Income or $50,000,000 when leverage ratio exceeds 2.50:1.
- Adjusted 'Consolidated Fixed Charge Coverage Ratio (FCCR)' to exclude convertible note prepayments/payments in full (capped at $200,000,000) from covenant measurements.
- Increased the allowable deduction for unrestricted cash when calculating Consolidated Total Net Indebtedness from $100,000,000 to $150,000,000 for Q4 2024 through Q2 2025.
Varex Imaging Corporation issued an 8-K to announce the release of its preliminary financial results for the third quarter and nine months ended June 28, 2024. The filing serves as a placeholder to incorporate the press release into the company's official record.
📋 Key Facts
- The filing is related to the announcement of preliminary results for the three and nine months ended June 28, 2024.
- The primary content is contained in Exhibit 99.1 (Press Release).
- Report date: August 1, 2024.
Varex Imaging Corporation issued an 8-K to announce the release of its preliminary financial results for the second quarter and first half of fiscal year 2024.
📋 Key Facts
- The company announced preliminary results for the three and six months ended March 29, 2024.
- The filing serves as a placeholder to furnish the press release containing the financial results (Exhibit 99.1).
- Report date: May 2, 2024.
Varex Imaging Corporation entered into a new $155 million senior secured revolving credit facility with Zions Bancorporation, N.A. to replace its existing asset-based revolving credit agreement with Bank of America.
🚩 Red Flags
- The new facility includes second liens on certain assets securing the company's 7.875% Senior Secured Notes due 2027, indicating a complex capital structure with multiple layers of secured debt.
📋 Key Facts
- New Credit Facility amount: up to $155 million in U.S. dollars and letters of credit.
- Maturity date: September 26, 2027.
- Interest rate: SOFR plus a margin of 2.00% to 2.75%, depending on the consolidated total net leverage ratio.
- The facility is secured by a first lien on assets including inventory, accounts receivable, cash, and certain real property.
- Existing Bank of America credit facility was terminated and paid off as of March 26, 2024.
- Proceeds are intended for working capital, general corporate purposes, and potential debt repayment.
Varex Imaging Corporation held its 2024 Annual Meeting of Stockholders on February 8, 2024. The filing reports the results of shareholder votes regarding director elections, executive compensation, a stock plan amendment, and the appointment of independent auditors.
📋 Key Facts
- The 2024 Annual Meeting was held on February 8, 2024, with approximately 92% of shares outstanding represented (37,292,203 shares).
- Seven directors were elected to serve until the 2025 Annual Meeting: Kathleen L. Bardwell, Jocelyn D. Chertoff, Timothy E. Guertin, Jay K. Kunkel, Walter M Rosebrough, Jr., Sunny S. Sanyal, and Christine A. Tsingos.
- Shareholders approved executive compensation on an advisory basis (Say-on-Pay).
- Shareholders approved the 2020 Omnibus Stock Plan, as Amended and Restated.
- Shareholders ratified the appointment of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year 2024.
Varex Imaging Corporation issued an 8-K to announce the release of its preliminary financial results for the first quarter of fiscal year 2024, covering the period ended December 29, 2023.
📋 Key Facts
- The filing announces preliminary results of operations for the three months ended December 29, 2023.
- Preliminary results were announced via a press release dated February 6, 2024.
- The announcement is intended to satisfy disclosure requirements under Item 2.02.